Voyager Therapeutics, Inc. (VYGR) Operating income 2016–2025
Voyager Therapeutics, Inc. (VYGR) annual operating income history from SEC filings — each fiscal year as reported.
-$131.8MFY2025 · since FY2016: -$41.3M → -$131.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$131.8M | -58.3% |
| FY2024 | -$83.3M | -168.3% |
| FY2023 | $122.0M | +340.0% |
| FY2022 | -$50.8M | +30.9% |
| FY2021 | -$73.6M | -368.8% |
| FY2020 | $27.4M | +153.0% |
| FY2019 | -$51.7M | +43.3% |
| FY2018 | -$91.1M | -26.8% |
| FY2017 | -$71.9M | -74.0% |
| FY2016 | -$41.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice